Published online October 5, 2009
PEDIATRICS Vol. 124 No. 5 November 2009, pp. e1007-e1013 (doi:10.1542/peds.2009-0567)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Haber, B. A.
Right arrow Articles by Schwarz, K. B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haber, B. A.
Right arrow Articles by Schwarz, K. B.
Related Collections
Right arrow Gastrointestinal Tract
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

SPECIAL ARTICLE

Recommendations for Screening, Monitoring, and Referral of Pediatric Chronic Hepatitis B

Barbara A. Haber, MDa, Joan M. Block, RN, BSNb, Maureen M. Jonas, MDc, Saul J. Karpen, MD, PhDd, W. Thomas London, MDe, Brian J. McMahon, MDf, Karen F. Murray, MDg, Michael R. Narkewicz, MDh, Philip Rosenthal, MDi and Kathleen B. Schwarz, MDj

a Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
b Hepatitis B Foundation, Doylestown, Pennsylvania
c Division of Gastroenterology, Children's Hospital Boston, Boston, Massachusetts
d Department of Pediatrics/Gastroenterology, Hepatology, and Nutrition, Baylor College of Medicine, Houston, Texas
e Fox Chase Cancer Center, Philadelphia, Pennsylvania
f Liver Disease and Hepatitis Program, Alaska Native Medical Center, Alaska Native Tribal Health Consortium, Anchorage, Alaska
g Division of Gastroenterology, Hepatology, and Nutrition, Seattle Children's and University of Washington School of Medicine, Seattle, Washington
h Department of Pediatrics, Section of Pediatric Gastroenterology, Hepatology, and Nutrition and Pediatric Liver Center, University of Colorado Denver School of Medicine and Children's Hospital, Aurora, Colorado
i Pediatric Hepatology, University of California, San Francisco, California
j Pediatric Liver Center, Division of Pediatric Gastroenterology and Nutrition, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland

Most children with chronic hepatitis B virus infection (persistent hepatitis B surface antigen–positive for >6 months) are asymptomatic and do not generally require treatment. These children are, however, at increased risk for severe complications later in life, including advanced liver disease and liver cancer. On November 11, 2008, the Hepatitis B Foundation, a nonprofit research and disease advocacy organization, convened a panel of nationally recognized North American pediatric liver specialists to consider and recommend an approach for the screening, monitoring, initial management, and referral of children with chronic hepatitis B. The panel developed recommendations to provide guidance to practitioners on determining what additional tests to conduct, how often to monitor on the basis of test results, and when to refer to a pediatric liver specialist to build a partnership between the practitioner and liver specialist to enhance the success of management of children with this lifelong infection.


Key Words: hepatitis B • chronic • pediatrics • screening • disease management • liver

Abbreviations: HBV—hepatitis B virus • HCC—hepatocellular carcinoma • HBsAg—hepatitis B surface antigen • anti-HBs—antibody to hepatitis B surface antigen • ALT—alanine aminotransferase • HBeAg—hepatitis B e-antigen • anti-HBe—antibody to hepatitis B e antigen • ULN—upper limit(s) of normal • CDC—Centers for Disease Control and Prevention • AFP—{alpha}-fetoprotein


Accepted Aug 7, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?